Tuesday broker round-up UPDATE
14th Oct 2014 09:17
Anglo Pacific: FinnCap upgrades to buy with a target price of 158p. Peel Hunt shifts target price from 196p to 198p retaining its buy recommendation. Ashmore: Canaccord Genuity upgrades from sell to hold with a target price of 300p. Numis cuts target price from 369p to 355p retaining an add rating.
Read moreMonday broker round-up UPDATE
13th Oct 2014 09:32
Amino Technologies: Northland Capital upgrades to buy with a target price of 100p. Anglo American: Canaccord Genuity initiates with a target price of 1720p and a buy recommendation. Credit Suisse upgrades to outperform with a target price of 1800p. Associated British Foods: Societe Generale upgrade
Read moreBTG to sell two drug treatments directly to 11 European countries
13th Oct 2014 07:58
Healthcare group BTG has announced its plans to start selling two of its oncology treatments directly to 11 European countries from 1 April next year. The move comes after the FTSE 250 group earlier this year began building a direct sales force to promote the approved uses of its products in major E
Read moreFTSE 250 movers: Telecom Plus climbs as oil stocks slide
10th Oct 2014 15:13
Utility services group Telecom Plus said it is happy with market expectations for the full year after strong organic growth in the first half, causing shares to surge on Friday. The company said that the strong growth in both customers and service numbers seen at the start of the year accelerated in
Read moreBTG to pay $6m to settle legal dispute with Bioclon over snake venom drug
10th Oct 2014 12:29
Specialist healthcare company BTG has settled its US patent infringement complaint against Instituto Bioclon and Rare Disease Therapeutics with a $6m payment. The FTSE 250-listed group has agreed to allow Bioclon to start selling its crotalid treatment from October 2018 if the Mexico-based firm rece
Read moreThursday broker round-up UPDATE
9th Oct 2014 09:27
African Barrick Gold: Numis reduces target price from 330p to 270p keeping its hold recommendation. Antofagasta: Numis upgrades to hold with a target price of 700p. Aureus Mining: Numis lowers target price from 45p to 40p staying with its buy recommendation. Boohoo: Barclays initiates with a targe
Read moreTuesday broker round-up UPDATE
7th Oct 2014 09:45
African Minerals: Canaccord Genuity lowers target price from 20p to 15p with a hold recommendation. Aggreko: Exane initiates with a target price of 1500p and an underperform rating. Amec: Liberum Capital cuts target price from 1035p to 908p staying with its sell recommendation. Antofagasta: Canacc
Read moreLondon open: Banks, supermarkets give FTSE 100 a lift
6th Oct 2014 08:37
Decent gains from banking and supermarket stocks gave the FTSE 100 a boost on Monday morning as the UK's benchmark index continues to recover after hitting a 10-month low last week. The Footsie was trading 0.4% higher at 6,554 early on, rising for the second straight day after falling to 6,446.39 la
Read moreBTG expects strong momentum to continue in second half
6th Oct 2014 08:15
BTG has given a bullish outlook for its annual performance after a strong start to the year, with the specialist healthcare company entering the second half "confident of continuing this strong momentum". In spite of adverse currency exchange movements, the group expects revenues to be around the to
Read moreBTG granted approval in China for liver cancer treatment
28th Aug 2014 07:54
Specialist healthcare company BTG and its partner SciClone Pharmaceuticals have received approval from the China Food and Drug Administration for the registration of its DC Bead treatment for a type of malignant liver tumour. Following the approval, the partners have started planning the treatment
Read moreLondon pre-open: FTSE set for small drop ahead of data
28th Aug 2014 07:48
Following a fairly flat session in the US on Wednesday evening, the FTSE is set for a modest decline at Thursday's opening bell, as investors look ahead to a busy day of data and company news. City sources predict the FTSE 100 will open around eight points lower than the previous day's close of 6,
Read moreSector movers: Astrazeneca boosts pharma stocks on Pfizer return hopes
21st Aug 2014 17:48
Astrazenca was leading the pharmaceuticals sector higher on Thursday on the back of speculation that US drug giant Pfizer could return with a fresh offer in the coming days. The reports lifted others in the sector higher in afternoon trading with peers such as Glaxosmithkline, Hikma and BTG making
Read moreTuesday broker round-up UPDATE
29th Jul 2014 09:37
Abderdeen Asset Management: Berenberg cuts target price from 530p to 510p and maintains a buy recommendation. African Barrick Gold: Numis takes target price from 260p to 330p upgrading from hold to buy. Anglo American: Deutsche Bank increases target price from 1590p to 1650p and reiterates a hold
Read moreLand Securities director acquires 10,000 shares
24th Jul 2014 16:26
Cressida Hogg, a Non-Executive Director of Land Securities, has spent £105,000 on 10,000 shares in the real estate investment trust. The purchase marks her only stake in the company. Meanwhile, Rolf Soderstrom, Chief Financial Officer at BTG has sold all of the 34,637 released under the group's
Read moreSector movers: Weak results, outlook from Glaxo sink pharma stocks
23rd Jul 2014 14:17
A slump in the share price of GlaxoSmithKline dragged the pharmaceuticals and biotechnology sector into the red on Wednesday as the drugmaker disappointed with a drop in quarterly sales and its full-year outlook. The company announced at midday that it has slashed its 2014 outlook as it reported a
Read more